HIV News and Research

RSS

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapeutics for treating COVID-19 and other diseases, wherein furin is integral for their pathogenicity and progression.

29 Mar 2022

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

A new approach from Penn Medicine researchers could cut the time it takes to alter patients' immune cells for infusion back into the body to find and attack cancer.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

New approach to help low- and middle-income countries reduce premature mortality from NCDs

Most of the world's countries have made little progress towards a target adopted by the United Nations in 2015, which called for the world to reduce premature mortality from non-communicable diseases by a third by 2030.

27 Mar 2022

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

A preliminary study to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases in Lisbon, Portugal (23-26 April), suggests that people living with HIV who are on antiretroviral treatment (ART) with protease inhibitors (PI), may have a lower risk of COVID-19 infection.

27 Mar 2022

SARS-CoV-2 virus may have lingering effects on peripheral nerves

Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people infected during the pandemic's early months experienced peripheral neuropathy - pain, tingling and numbness in the hands and feet - during and following their bouts with the virus.

25 Mar 2022

Physical activity boosts cognitive performance in middle-aged and older adults, study shows

A new study by researchers at The University of California San Diego School of Medicine adds to the canon of research associating physical activity with cognitive performance, this time using 90 middle-aged and older participants who wore accelerometers while physically active and completed mobile cognitive testing from home.

24 Mar 2022

Breast milk components show potent in vitro SARS-CoV-2 inhibition

Human breastmilk contains substances that can inhibit infection by SARS-CoV-2 and its variants, as well as prevent its replication.

24 Mar 2022

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

The National Institute of Health awarded $436,642 to associate professor of biomedical engineering, Kartik Balachandran, to study the downstream effects of acute respiratory syndrome coronavirus 2 on the aortic valve.

24 Mar 2022

Short duration treatment effective in combating most childhood TB cases, study says

Short duration treatment — four months instead of the standard six — is as effective in combating most cases of childhood tuberculosis (TB), says a study carried out in India and some African countries.

24 Mar 2022

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

For World Tuberculosis Day 2022, News Medical spoke to Dr. Maxine Caws to raise awareness of this infectious disease.

24 Mar 2022

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use.

23 Mar 2022

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

New York Blood Center’s Project ACHIEVE and Columbia University’s Columbia Research Unit are working in partnership for the New York City effort to advance the use of messenger ribonucleic acid (mRNA) technology in an HIV preventive vaccine study – HVTN 302.

23 Mar 2022

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

Researchers evaluate antiviral effects of CD63 tetraspanin extracellular vesicles against SARS-CoV-2 and HIV-1.

22 Mar 2022

The importance of the endosomal pathway for SARS-CoV-2 entry

Researchers demonstrated that combined inhibition of cell-surface-based and endosomal pathways completely blocked SARS-CoV-2 entry into mammalian cells.

21 Mar 2022

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

Researchers from different countries examined various animal species from wildlife trade sites to detect the presence of zoonotic pathogens in Laos, South East Asia.

18 Mar 2022

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Researchers conducted a prospective household cohort study of COVID-19, influenza, and respiratory syncytial virus community burden, viral interaction, and transmission dynamics, called PHIRST-C study in South Africa.

18 Mar 2022

Study finds high rates of cancer among men living with HIV

Researchers with Case Western Reserve University have found that there are nearly twice as many men with cancer among men living with HIV (MLWH) compared to men who do not have the human immunodeficiency virus.

17 Mar 2022

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

Researchers constructed a novel fusion inhibitor−based recombinant protein, referred to as 5−Helix, to block SARS-CoV-2 spike-mediated cell-cell fusion.

17 Mar 2022

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Researchers compared the efficacy of booster doses of heterologous intramuscular and aerosolized adenovirus-vectored vaccine, a recombinant protein-based ZF2001 vaccine, and homologous CoronaVac vaccines.

17 Mar 2022

HIV News and Research

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Penn researchers generate functional CAR T cells with enhanced anti-tumor potency in 24 hours

Algal metabolites as novel drugs against viruses

New approach to help low- and middle-income countries reduce premature mortality from NCDs

HIV patients on antiretroviral treatment with protease inhibitors may have lower COVID-19 risk

SARS-CoV-2 virus may have lingering effects on peripheral nerves

Physical activity boosts cognitive performance in middle-aged and older adults, study shows

Breast milk components show potent in vitro SARS-CoV-2 inhibition

U of A researcher receives $436,642 from NIH to study effects of SARS-COV-2 on the aortic valve

Short duration treatment effective in combating most childhood TB cases, study says

World Tuberculosis Day 2022: an interview with Dr. Maxine Caws

New nanoparticle-based COVID-19 vaccine platform could target other infectious diseases

New York Blood Center and Columbia University partner to advance the use of mRNA technology in HIV vaccine study

CD63-expressing extracellular vesicles neutralize SARS-CoV-2 variants of concern

The importance of the endosomal pathway for SARS-CoV-2 entry

Presence of zoonotic pathogens in wildlife market for human consumption in Laos

SARS-CoV-2 burden and transmission in one rural and one urban community in South Africa

Study finds high rates of cancer among men living with HIV

Novel fusion inhibitor blocks SARS-CoV-2 spike-mediated cell-cell fusion

The immunogenicity of homologous and heterologous boosters in adults who received inactivated COVID-19 vaccine six months prior

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News